Lilly Ventures Fund I LLC 13D/13G Filings for Protagonist Therapeutics, Inc. (PTGX)

Lilly Ventures Fund I LLC 13D and 13G filings for Protagonist Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2020-06-08
4:04 pm
Sale
2020-05-11 13D Protagonist Therapeutics, Inc.
PTGX
Lilly Ventures Fund I LLC 1,559,060
4.500%
-540,422decrease
(-25.74%)
Filing